摘要
目的:评价4种中成药治疗肝纤维化的经济学效果。方法:84例门诊肝纤维化患者随机接受大黄蛰虫胶囊(A组)、扶正化瘀胶囊(B组)、复方鳖甲软肝片(C组)、鳖甲煎丸(D组)治疗,以药物经济学方法进行成本-效果分析。结果:A、B、C、D组的总成本(C)分别为835.2、1228.5、1922.4、488.0元(P<0.05),总有效率(E)分别为76.19%、80.95%、85.71%、80.95%(P<0.05),成本-效果比(C/E)分别为10.96、15.18、22.43、6.03(P<0.05)。结论:4种中成药中,鳖甲煎丸治疗肝纤维化成本-效果较优。
OBJECTIVE： To analyze the cost-effectiveness of 4 kinds of Chinese patent drugs in the treatment of hepatic fibrosis. METHODS：84 patients with hepatic fibrosis were treated with Dahuang Zhechong capsule （group A）, Fuzheng Huayu capsule （group B）, Fufang Biejia Ruangan tablet （group C） and Biejia Jian pill （group D）, respectively. Then cost-effectiveness was analyzed with pharmacoeconomic method. RESULTS： The total costs （C） were 835.2 yuan for group A, 1228.5 yuan for group B, 1922.4 yuan for group C and 488 yuan for group D. The total effective rates （E） were 76.19%, 80.95%, 85.71%, 80.95%, respectively （P〈0.05）. The average cost-effect ratios （C/E） were 10.96, 15.18, 22.43 and 6.03, respectively. CONCLUSION：Biejia Jian pill （group D） is the most economical one among 4 drugs for hepatic fibrosis.
出处
《中国药房》
CAS
CSCD
北大核心
2010年第4期374-375,共2页
China Pharmacy
关键词
肝纤维化
大黄蛰虫胶囊
扶正化瘀胶囊
复方鳖甲软肝片
鳖甲煎丸
成本-效果分析
Hepatic fibrosis
Dahuang Zhechong capsule
Fuzheng Huayu capsule
Fufang Biejia Ruangan tablet
Biejia Jian pill
Cost-effectiveness analysis
